Agility Life Sciences
Agility Life Sciences
  • Home
  • Menu
    • Our Expertise
    • Our Tribe
    • Our Culture
    • Contact Us
    • News and Events
  • More
    • Home
    • Menu
      • Our Expertise
      • Our Tribe
      • Our Culture
      • Contact Us
      • News and Events
  • Sign In

  • My Account
  • Signed in as:

  • filler@godaddy.com


  • My Account
  • Sign out


Signed in as:

filler@godaddy.com

  • Home
  • Menu
    • Our Expertise
    • Our Tribe
    • Our Culture
    • Contact Us
    • News and Events

Account


  • My Account
  • Sign out


  • Sign In
  • My Account

Our Expertise

Solubility Issues

A limiting factor for many new drug candidates, we use the following approaches to increase the solubility of molecules:


  • Solubility enhancing excipients
  • Spray drying to produce amorphous API or dispersions
  • Amorphous solid dispersions
  • Milling and nanomilling
  • Lipid nanoparticles and liposomes



Permeability Issues

To overcome permeability issues, we use multiple approaches, including:


  • Permeability enhancing excipients
  • Lipid nanoparticles and liposomes
  • Cell penetrating peptides
  • Pertinent for indications such as Alzheimer's or Parkinson's disease and drugs targeting the central nervous system.


Extending Your Molecule's Release Profile

To extend, sustain or modify the release profile of formulations, we use the following approaches:


  • Size reduction using milling or nanomilling
  • Matrix formation using polymers to slow release of the drug
  • Coasting of particles, granules, capsules or tablets
  • Layering of components within the drug product



Formulation Types

We can develop and supply a variety of formulation types including:


  • Tablets, capsules, caplets and lozenges: Immediate, modified and sustained release
  • Liquids and suspensions: Oral, IV, ocular, and nanosuspensions
  • Lipid nanoparticles and liposomes
  • Creams, gels and ointments
  • Powder blends

Routes of Administration

We have demonstrated expertise in making formulations for the following routes of administration:


  • Oral: Tablet, caplets, capsules, solutions, suspensions and nanosuspensions
  • Buccal and sublingual: Tablets and lozenges
  • Subcutaneous: Solutions, suspensions and depots
  • Intranasal: Gels and solutions, particularly for crossing the blood brain barrier
  • Ocular: Gels, solutions, nano suspensions and IVTs
  • Intravenous: Solutions and depots
  • Transdermal: Creams, gels and ointments

Analytical Method Development

In order to demonstrate our formulation approaches are effective:

  • We develop and appropriately validate analytical methods specific to the molecule.
  • We also develop and validate HPLC methods as part of formulation projects, or as standalone projects.

Consulting

We also offer CMC, analytical and formulation development consulting services as well as writing the CMC sections for regulatory documents.

  • Our Expertise
  • Our Tribe
  • Our Culture
  • Contact Us
  • News and Events

Agility Life Sciences

Agility Life Sciences, Springcourt House, High Street, Stapleford, Nottingham, NG9 8AG

Copyright © 2025 Agility Life Sciences - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept